These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11428978)
21. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833 [TBL] [Abstract][Full Text] [Related]
22. Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan. Shao PL; Lu MY; Liau YJ; Kao CL; Chang SY; Huang LM J Formos Med Assoc; 2012 Aug; 111(8):456-60. PubMed ID: 22939665 [TBL] [Abstract][Full Text] [Related]
23. Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir. Abraham B; Lastere S; Reynes J; Bibollet-Ruche F; Vidal N; Segondy M J Clin Virol; 1999 Aug; 13(3):141-8. PubMed ID: 10443790 [TBL] [Abstract][Full Text] [Related]
24. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report. Green CB; O'Riordan A; Griffiths P; Haque T J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599 [TBL] [Abstract][Full Text] [Related]
25. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554 [TBL] [Abstract][Full Text] [Related]
26. Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples. Hall Sedlak R; Castor J; Butler-Wu SM; Chan E; Cook L; Limaye AP; Jerome KR J Clin Microbiol; 2013 Jul; 51(7):2354-9. PubMed ID: 23678068 [TBL] [Abstract][Full Text] [Related]
27. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Baldanti F; Lurain N; Gerna G Hum Immunol; 2004 May; 65(5):403-9. PubMed ID: 15172438 [TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748 [TBL] [Abstract][Full Text] [Related]
32. Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. Jabs DA; Martin BK; Forman MS; Dunn JP; Davis JL; Weinberg DV; Biron KK; Baldanti F; Hu H; Am J Ophthalmol; 2001 Nov; 132(5):700-10. PubMed ID: 11704031 [TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173 [TBL] [Abstract][Full Text] [Related]
34. Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Eckle T; Prix L; Jahn G; Klingebiel T; Handgretinger R; Selle B; Hamprecht K Blood; 2000 Nov; 96(9):3286-9. PubMed ID: 11050017 [TBL] [Abstract][Full Text] [Related]
35. [Mechanism of drug-resistance in human cytomegalovirus]. Eizuru Y Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():476-9. PubMed ID: 17455666 [No Abstract] [Full Text] [Related]
36. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. Jabs DA; Martin BK; Forman MS; Dunn JP; Davis JL; Weinberg DV; Biron KK; Baldanti F; J Infect Dis; 2001 Jan; 183(2):333-337. PubMed ID: 11120934 [TBL] [Abstract][Full Text] [Related]
37. High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations. Baradhi KM; Aure RL; El-Amm JM Transplant Proc; 2018; 50(1):142-144. PubMed ID: 29407298 [TBL] [Abstract][Full Text] [Related]
38. The biology of cytomegalovirus drug resistance. Hakki M; Chou S Curr Opin Infect Dis; 2011 Dec; 24(6):605-11. PubMed ID: 22001948 [TBL] [Abstract][Full Text] [Related]
39. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients. Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537 [TBL] [Abstract][Full Text] [Related]
40. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. Chou S; Marousek G; Parenti DM; Gordon SM; LaVoy AG; Ross JG; Miner RC; Drew WL J Infect Dis; 1998 Aug; 178(2):526-30. PubMed ID: 9697736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]